356 citations
,
September 2014 in “Journal of Clinical Research in Pediatric Endocrinology” This article discusses the rising prevalence and serious implications of childhood obesity and reports no new experimental findings; the authors emphasize the importance of prevention and early intervention through comprehensive management programs.
May 2022 in “Acta Scientific Women's Health” This case report describes a 45-year-old unvaccinated woman who experienced severe telogen effluvium, losing over 80% of her hair, about three months after recovering from COVID-19.
114 citations
,
January 2007 in “Drug Safety” This review discusses various adverse drug reactions affecting the skin, hair, and nails, emphasizing the importance of recognizing and reporting these reactions but reports no new clinical findings.
90 citations
,
October 2023 in “Advanced Drug Delivery Reviews” This review highlights that unresolved inflammation is a major issue in diabetic foot ulcers and discusses emerging biomaterials-based strategies to modulate the inflammatory response, potentially aiding in tissue regeneration and healing in these chronic wounds.
119 citations
,
June 2005 in “Journal of Molecular and Cellular Cardiology” This article reviews the therapeutic potential of potassium channel openers for various conditions related to metabolic distress but does not report new clinical results; it emphasizes the need for further research.
213 citations
,
June 2017 in “Rheumatology” This guideline outlines the management of systemic lupus erythematosus in adults but reports no new clinical findings.
17 citations
,
September 2024 in “The Indian Journal of Medical Research” This source explores long COVID syndrome and identifies risk factors like older age, female gender, and comorbidities such as diabetes. It mentions potential diagnostic biomarkers, highlights ongoing clinical trials, and emphasizes the importance of vaccines and rehabilitation in managing long COVID.
1 citations
,
December 2022 in “Journal of Family Medicine and Primary Care” This study found that post-COVID-19 syndrome led to long-term health issues for many participants, underscoring the need for preventive measures and patient-centered programs to reduce complications.
January 2026 in “International Journal of Molecular Sciences” This narrative review highlights that declining testosterone levels are a complex public health issue potentially influenced by modifiable lifestyle factors and environmental stressors, suggesting integrated strategies may be needed to address the trend's impacts on health.
October 2025 in “Journal of Pharmacy And Bioallied Sciences” In this observational study conducted at a tertiary care center, researchers found that post-COVID patients most commonly experienced telogen effluvium and other dermatological issues like herpes infection and acne, with middle-aged and female patients being predominantly affected.
4 citations
,
October 2022 in “Journal of family medicine and primary care” This study observed a high prevalence of hair loss among adults after receiving COVID-19 vaccination, with two-thirds of participants experiencing this issue and a minority of cases possibly vaccine-related.
139 citations
,
December 2021 in “Journal of Clinical Medicine” This systematic review reports that fatigue was the most common symptom in both phases of long COVID, with lung function issues more frequent in the ongoing symptomatic phase and psychological burdens like anxiety and depression more prevalent in the post-COVID syndrome phase.
66 citations
,
December 2003 in “Endocrinology and Metabolism Clinics of North America” This article emphasizes the need for physicians to gain expertise in obesity care, detailing comprehensive assessments as critical for effective management, but provides no new research findings.
9 citations
,
September 2022 in “Journal of Clinical Investigation” In this study, mouse models of 22q11.2 deletion syndrome showed that growth issues in small embryonic thymuses were linked to mesenchymal cells, which could be corrected by substituting with normal mesenchyme.
2 citations
,
September 2022 in “Cureus” In this study conducted in the Makkah region, researchers observed that hair loss, mostly telogen effluvium, is a prevalent post-COVID-19 symptom, particularly among women and those with multiple health issues.
1 citations
,
February 2025 in “International Journal of Scientific Research and Management (IJSRM)” This article examines challenges in the pharmaceutical supply chain during pandemics, highlighting issues like raw material sourcing and distribution delays, and suggests enhancements such as AI, blockchain, and public-private alliances to ensure stability and resilience.
1 citations
,
December 2023 in “Annals of Phytomedicine An International Journal” In this review, the researchers discuss how nanoemulgel overcomes the limitations of lipophilic phytomolecules by improving their bioavailability, penetration, and therapeutic efficacy, making it a promising nanocarrier for the treatment of various health conditions.
July 2025 in “Journal of Clinical Research and Reports” This abstract provides a narrative overview of polycystic ovary syndrome, discussing its symptoms and related health issues, and does not include new research findings.
July 2022 in “International Journal of Health Sciences” This review discusses various long-term complications among COVID-19 survivors, reporting no new clinical results, and underlines the need for vigilant monitoring by healthcare providers.
The books were useful but had some areas needing improvement.
13 citations
,
January 2011 in “Lung India” This case study observed isoniazid-induced alopecia in a patient, which was confirmed as reversible since hair regrowth resumed after the drug was discontinued.
2 citations
,
January 2015 in “BioMed Research International” This article reviews various aspects of growth factor research, highlighting their role in treatments and emphasizing the need for further clinical trials to validate their efficacy in biomedical applications.
November 2022 in “Journal of the Endocrine Society” This case report describes a patient with ectopic Cushing's syndrome who experienced fatal complications from COVID-19, highlighting the challenges in managing such patients due to immune response alterations from endogenous hypercortisolemia.
September 2021 in “RECISATEC - REVISTA CIENTÍFICA SAÚDE E TECNOLOGIA - ISSN 2763-8405” This review explores the role of the biomedical esthetician and the potential benefits of platelet-rich plasma in treating hair loss after COVID-19, without presenting new clinical results.
556 citations
,
September 2008 in “Genes & Development” This review summarizes how genetic studies using conditional β-catenin loss- and gain-of-function mice have advanced understanding of canonical Wnt signaling's role in embryonic development, adult stem cell maintenance, and cancer modeling.
374 citations
,
May 2016 in “The Lancet. Diabetes & endocrinology” This article reviews the clinical complications and increased mortality risks associated with Cushing's syndrome but does not present new clinical data; it emphasizes the need for prompt treatment to mitigate these risks.
363 citations
,
May 2006 in “Current Opinion in Psychiatry” This review highlights that medical complications, notably in anorexia nervosa, are common and often serious in patients with eating disorders, affecting multiple organ systems.
128 citations
,
September 2011 in “British Journal of Dermatology” Obesity is linked to various skin problems and may increase the risk of skin cancer.
115 citations
,
November 2015 in “The journal of allergy and clinical immunology/Journal of allergy and clinical immunology/The journal of allergy and clinical immunology” This review discusses the impact of sleep cycles and circadian rhythms on nighttime exacerbation of atopic dermatitis in children and presents potential treatment options for related sleep disturbances, but reports no new clinical results.
114 citations
,
December 1951 in “Archives of Dermatology” This article reviews the effectiveness of adrenal cortex compounds E and F in treating various connective tissue disorders and reports no new clinical findings.